Memphis Pharmaceutical & Chemical Industries (MPCI) Key Statistics
26 reported figures for Memphis Pharmaceutical & Chemical Industries — valuation multiples, the latest fiscal year's income statement, balance-sheet totals, growth rates and technical readings. Figures with no reported value are omitted rather than shown as zero.
Valuation
- Market cap
- EGP 9.67B
- P/E (trailing)
- 18.52
- P/B
- 12.46
- Dividend yield
- 3.1%
Income (latest fiscal year)
- Revenue
- EGP 1.51B
- Net income
- EGP 505.28M
- EBITDA
- EGP 597.02M
- Free cash flow
- EGP 197.98M
- Profit margin
- 33.51%
Balance sheet
- Total assets
- EGP 1.49B
- Total debt
- EGP 101.6M
- Book value
- EGP 770.54M
Growth
- Revenue growth
- 72.93%
- Profit growth
- 163.91%
- EPS growth
- 96.01%
Per share
- EPS (fiscal year)
- 22.21
- Book value per share
- 33.87
- Dividend per share
- 13.187
- Return on equity
- 109.89%
- Return on assets
- 37.29%
Technical
- RSI (14)
- 62.8
- 50-day moving average
- EGP 333.52
- 200-day moving average
- EGP 212.36
- Beta (1Y)
- 0.32
Shares
- Shares outstanding
- 22.75M
- Free float
- 21.48%
Source: company disclosures to the Egyptian Exchange via TradingView. Fiscal-year figures are as last reported; technical readings refresh with market data.